RNAC – cartesian therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Cartesian Therapeutics Announces the Appointment of Adrian Bot to Board of Directors [Yahoo! Finance]
Cartesian Therapeutics Announces the Appointment of Adrian Bot to Board of Directors
Cartesian Therapeutics (NASDAQ:RNAC) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Cartesian Therapeutics (NASDAQ:RNAC) had its price target lowered by analysts at HC Wainwright from $40.00 to $30.00. They now have a "buy" rating on the stock.
Cartesian Therapeutics (NASDAQ:RNAC) had its price target raised by analysts at BTIG Research from $42.00 to $44.00. They now have a "buy" rating on the stock.
Form 4 Cartesian Therapeutics, For: Dec 16 Filed by: Bot Adrian Ion
Form 3 Cartesian Therapeutics, For: Dec 16 Filed by: Bot Adrian Ion
Form 8-K Cartesian Therapeutics, For: Dec 16
Form 4 Cartesian Therapeutics, For: Dec 04 Filed by: BARABE TIMOTHY C
Form 4 Cartesian Therapeutics, For: Nov 28 Filed by: English Emily
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.